COVID-19 BNT162b2 mRNA vaccine for patients with type 2 diabetes mellitus

COVID-19, diabetes mellitus type 2, endocrine genetics, and pituitary and adrenal diseases

“…As mentioned last summer [1], Hormones continues to have keen interest in COVID-19, the endocrine morbidity associated with it, as well as what was initially called "long-COVID-19" syndrome, also known as "post-COVID-19 conditions" (PCC): the latter condition may, in fact, be in large part due to hormonal dysfunction [2]. The current issue of Hormones features reports and correspondence on the administration of the COVID-19 BNT162b2 mRNA vaccine, publications that add significantly to the field [3][4][5][6]. It is truly amazing what we are learning today about both the disease and the vaccinations together with their possible long-lasting effects.…”